Your browser doesn't support javascript.
loading
Genetic Stratification of Age-Dependent Parkinson's Disease Risk by Polygenic Hazard Score.
Pihlstrøm, Lasse; Fan, Chun C; Frei, Oleksandr; Tan, Manuela; Karunamuni, Roshan A; Blauwendraat, Cornelis; Bandres-Ciga, Sara; Gan-Or, Ziv; Grosset, Donald G; Dale, Anders M; Seibert, Tyler M; Andreassen, Ole A.
Afiliación
  • Pihlstrøm L; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Fan CC; Department of Cognitive Science, University of California San Diego, La Jolla, California, USA.
  • Frei O; Center for Multimodal Imaging and Genetics, School of Medicine, University of California San Diego, La Jolla, California, USA.
  • Tan M; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Karunamuni RA; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
  • Blauwendraat C; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Bandres-Ciga S; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
  • Gan-Or Z; Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Grosset DG; Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Dale AM; Department of Human Genetics, McGill University, Montreal, Québec, Canada.
  • Seibert TM; Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada.
  • Andreassen OA; Department of Neurology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Mov Disord ; 37(1): 62-69, 2022 01.
Article en En | MEDLINE | ID: mdl-34612543
BACKGROUND: Parkinson's disease (PD) is a highly age-related disorder, where common genetic risk variants affect both disease risk and age at onset. A statistical approach that integrates these effects across all common variants may be clinically useful for individual risk stratification. A polygenic hazard score methodology, leveraging a time-to-event framework, has recently been successfully applied in other age-related disorders. OBJECTIVES: We aimed to develop and validate a polygenic hazard score model in sporadic PD. METHODS: Using a Cox regression framework, we modeled the polygenic hazard score in a training data set of 11,693 PD patients and 9841 controls. The score was then validated in an independent test data set of 5112 PD patients and 5372 controls and a small single-study sample of 360 patients and 160 controls. RESULTS: A polygenic hazard score predicts the onset of PD with a hazard ratio of 3.78 (95% confidence interval 3.49-4.10) when comparing the highest to the lowest risk decile. Combined with epidemiological data on incidence rate, we apply the score to estimate genetically stratified instantaneous PD risk across age groups. CONCLUSIONS: We demonstrate the feasibility of a polygenic hazard approach in PD, integrating the genetic effects on disease risk and age at onset in a single model. In combination with other predictive biomarkers, the approach may hold promise for risk stratification in future clinical trials of disease-modifying therapies, which aim at postponing the onset of PD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Noruega